Abiopharma

🔍 Edwards Barbara Joanne (Director)

Company: STANDEX INTERNATIONAL CORP/DE/ (SXI)

Report Date: 2026-08-23

Detailed Transactions and Holdings:

• Acquired 143 shares of Phantom Stock Units (Derivative)
  Date: 2026-08-23 | Code: A | Expires: 2029-08-23 | Exercise: 2029-08-23 | equity_swap_involved: 0 | shares_owned_after: 143.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Contingent Purchase of Phantom Stock of the Company pursuant to the Management Stock Purchase Plan component of the 2018 Omnibus Incentive Plan vesting three years after the date of purchase in the form of Common Stock.